Vital SignsVital SignsCheck your MP →
KCLEmily Simonoff — no licensed photograph is available, so the academic plate is shown instead.

Academic

Emily Simonoff

Professor of Child and Adolescent Psychiatry; Head of Department of Child and Adolescent Psychiatry, King's College London – Institute of Psychiatry, Psychology & Neuroscience

King's College London – Institute of Psychiatry, Psychology & Neuroscience is based in Peckham (London) — the organisation’s base, not a personal address.

Press citations

1

Topic

1

Hospital discharge / bed-blocking

Last quoted

Aug 2026

Emily Simonoff: key facts

Kind of voice
Academic
Role
Professor of Child and Adolescent Psychiatry; Head of Department of Child and Adolescent Psychiatry
Organisation
King's College London – Institute of Psychiatry, Psychology & Neuroscience
Organisation based in
Peckham
Quoted on
Hospital discharge / bed-blocking
Tracked press citations
1
Most recently quoted
27 Aug 2026

Who Emily Simonoff is

Professor Emily Simonoff is Professor of Child and Adolescent Psychiatry at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, where she heads the Department of Child and Adolescent Psychiatry and serves as Academic Lead for the CAMHS Clinical Academic Group in King's Health Partners. Her research focuses on neurodevelopmental disorders — particularly autism, ADHD, and intellectual disability — spanning epidemiological cohorts, clinical trials, and studies of underlying disease mechanisms. She is an NIHR Emeritus Senior Investigator and serves as Chief Investigator of the PATHWAYS study, a £10.7 million NHS England and NIHR-funded programme examining puberty suppression and transitional care for young people with gender incongruence. Her external roles include Chair of the European ADHD Guidelines Group and past Senior Clinical Advisor to NICE, and her research has directly informed NICE guidance on ADHD and autism. She has been widely quoted in UK press — including the Guardian and ITV News — on the clinical evidence base for treatments in child and adolescent mental health.

“One might want to argue that puberty suppression should never have been made available to young people outside of a clinical trial some 10 or 15 years ago, and the most ethical thing would have been to do a trial at that point in time.”

References for this biography

  1. 1.Emily Simonoff – King's College London staff profile — Current role (Professor, Head of Department, CAMHS Clinical Academic Group lead), external positions including Chair of European ADHD Guidelines Group, and PATHWAYS project leadership
  2. 2.Professor Emily Simonoff – NIHR — NIHR Emeritus Senior Investigator status; research focus on autism, ADHD and gender incongruence
  3. 3.PATHWAYS: Puberty Suppression and Transitional Healthcare with Adaptive Youth Services – King's College London — Confirms Simonoff as Chief Investigator; describes study scope and funding (NIHR/NHS England partnership)
  4. 4.PATHWAYS TRIAL and CONNECT launch – King's College London — Press-quoted role as Chief Investigator; confirms KCL/SLaM co-sponsorship and study design
  5. 5.Professor Emily Simonoff – South London and Maudsley NHS Foundation Trust — Clinical career background; Chair of European ADHD Guidelines Group; research informing NICE guidance; Head of Department since 2008; Professor since 2004
  6. 6.Committee membership list – ADHD guideline (update) – NICE — Confirms role as Clinical Advisor to the NICE ADHD guideline development committee
  7. 7.PATHWAYS Horizon study launch – Science Media Centre — Press-quoted as Chief Investigator of the PATHWAYS studies on gender incongruence

Notable achievements

  • Confirmed as Chief Investigator of the PATHWAYS study — a £10.7 million NIHR/NHS England-funded clinical programme on puberty suppression and gender-incongruence care in young people, led by King's College London and co-sponsored by South London and Maudsley NHS Foundation Trust. Source ↗
  • Served as Clinical Advisor to the NICE guideline development committee on ADHD (update), as listed in the published NICE committee membership. Source ↗
  • Chairs the European ADHD Guidelines Group, a multidisciplinary clinical-academic body responsible for assessing evidence and issuing recommendations on ADHD assessment and treatment. Source ↗
  • Her work on co-occurring mental health conditions in children with autism fed into two sets of NICE guidance: on ADHD diagnosis/treatment and autism diagnosis. Source ↗

Where Emily Simonoff has been quoted

  1. Two UK clinical trials to assess impact of puberty blockers in young peopletheguardian.com · 27 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Contact & links

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.